Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study

OBJECTIVES: Blinatumomab was shown to be safe and effective for consolidation therapy in B-cell acute lymphoblastic leukemia (B-ALL). This study aimed to investigate the effectiveness and safety of blinatumomab in pediatric B-ALL patients in a real-world setting. METHODS: This was a retrospective, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ying, Li, Yanming, Fan, Jia, Qi, Peijing, Lin, Wei, Yang, Jie, Liu, Huiqing, Wang, Xiaoling, Zheng, Huyong, Wang, Tianyou, Zhang, Ruidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638881/
https://www.ncbi.nlm.nih.gov/pubmed/36353258
http://dx.doi.org/10.3389/fped.2022.1034373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638881/
https://www.ncbi.nlm.nih.gov/pubmed/36353258
http://dx.doi.org/10.3389/fped.2022.1034373

Ejemplares similares